RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors

Erik C Dreaden1,2,3, Yi Wen Kong1,4, Mohiuddin A Quadir1,2,5

  • 1Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge MA 02139.

Insights

This study developed a nanoscale therapy to resensitize ovarian cancer to chemotherapy. Combining RNA interference targeting MK2 with chemotherapy significantly improved survival and reduced metastasis in mouse models.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • DNA damaging chemotherapy is standard for advanced ovarian cancer (OC).
  • Most patients initially respond but develop chemo-resistance, necessitating novel adjuvant therapies.
  • Improved treatment strategies are crucial for enhancing survival in advanced OC.

Purpose of the Study:

  • To develop a nanoscale therapy to chemosensitize advanced ovarian tumors to platinum/taxane chemotherapy.
  • To investigate the efficacy of RNA interference targeting MK2 (a protein kinase) in overcoming chemo-resistance.
  • To evaluate the safety and effectiveness of peptide nanoplexes as delivery vectors for siRNA.

Main Methods:

  • Development of a nanoscale peptide-nucleic acid complex for tumor-specific RNA interference (RNAi).
  • Silencing of the protein kinase MK2 using nanoplex-mediated RNAi in mouse models of high-grade serous OC.
  • Assessment of chemosensitization to platinum/taxane therapy and impact on cell cycle checkpoints.

Main Results:

  • Nanoplex-mediated MK2 silencing profoundly sensitized OC models to chemotherapy by blocking p38/MK2-dependent cell cycle checkpoints.
  • Combined RNAi therapy improved overall survival by 37% compared to chemotherapy alone.
  • A significant decrease in lung metastasis was observed without apparent toxic side effects.

Conclusions:

  • Peptide nanoplexes are safe and effective delivery vectors for small interfering RNA (siRNA).
  • Combined inhibition of MK2 can enhance treatment outcomes for advanced ovarian cancer patients undergoing frontline chemotherapy.
  • This approach offers a promising strategy to overcome chemo-resistance in ovarian cancer.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.7K
Graded Potential01:19

Graded Potential

Graded potentials are localized fluctuations in the cell membrane's electrical charge, commonly found in the dendrites of neurons. The magnitude of these potential changes depends on the strength of the initiating stimulus. In a membrane at its resting potential, a graded potential signifies a voltage shift either above -70 mV or below -70 mV.
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
7.2K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.8K